Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.3B | 1.3B | 1.2B | 1.2B |
Cost of revenue | 361M | 491M | 340M | 340M |
Gross profit | 918M | 790M | 831M | 829M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 59M | 54M | 53M | 43M |
Other operating expenses | 15M | 19M | 14M | 14M |
Operating income | 857M | 739M | 778M | 786M |
Non operating interest income | ||||
Income | 56M | 61M | 49M | 41M |
Expense | 315M | 318M | 331M | 300M |
Other income expense | — | — | — | — |
Pretax income | 1.0B | 1.3B | 502M | 286M |
Tax provision | 222M | 264M | 108M | 67M |
Net income | 782M | 997M | 393M | 219M |
Basic EPS | 8 | 10 | 4 | 2 |
Diluted EPS | 8 | 10 | 4 | 2 |
Basic average shares | 97.3M | 99.3M | 98M | 109.5M |
Diluted average shares | 97.3M | 99.3M | 98M | 109.5M |
EBITDA | 1.3B | 1.4B | 942M | 552M |
Net income from continuing op. | 542M | 489M | 433M | 503M |
Minority interests | -4M | -4M | -1M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |